Our main purpose is to develop Chugai's development candidates (from Chugai's own research efforts or via licensing-in agreements and collaborations) from the pre-clinical stage through to Phase III, as part of an international development team.
Additionally, we support European licensing activities and provide market information and support for the European region to other parts of the Chugai group.Chugai Pharmaceutical Co. Ltd., specializes in prescription pharmaceuticals and based in Tokyo, is one of Japan's leading research-based pharmaceutical companies with strengths in biotechnology products. Since the start of the strategic alliance with Roche in October 2002, Chugai has been actively involved in prescription pharmaceutical R&D activities in Japan and abroad as an important member of the Roche Group. Specifically, Chugai is working to develop innovative products with global applications, focusing on the disease areas of oncology, renal disease, and bone and joint. In Japan, Chugai's research facilities in Gotemba and Kamakura are collaborating to develop new pharmaceuticals and Ukima is conducting research for technology development for industrial production. Overseas, Chugai Pharma USA and Chugai Pharma Europe are engaged in clinical development activities in the United States and Europe. The consolidated sales in 2007 of Chugai totalled 344.8 billion yen and the operating profit was 66.7 billion yen.
For more information on roles within this company please contact your Chugai Account Manager